GlassScriptPhysician profile
Phillip H Behrens
NPI 1710470091
$15,386.21
in general payments reported to CMS, 2019-2025
13 companies · $1,406 in 2025
The $1,406 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,774 · 2020: $628 · 2021: $1,144 · 2022: $5,287 · 2023: $2,967 · 2024: $1,179 · 2025: $1,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,959 · Food and Beverage: $1,594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,958.72 |
| Food and Beverage | $1,594.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,960.58 | 2019-2025 | Makoplasty |
| Biedermann Motech, INC. | $2,922.25 | 2022-2023 | Moss100 Pedicle Screw System |
| Alphatec Spine, INC | $2,712.59 | 2020-2024 | Other - Miscellaneous |
| Medtronic, INC. | $1,893.34 | 2021-2022 | |
| Si-Bone, INC. | $1,193.90 | 2022-2023 | |
| Synthes Gmbh | $877.21 | 2021 | |
| Globus Medical, INC. | $702.25 | 2021-2022 | |
| Medical Device Business Services, INC. | $445.30 | 2019 | |
| Depuy Synthes Sales INC. | $244.84 | 2020-2025 | Vivigen Mis Delivery System |
| Nuvasive, INC. | $214.45 | 2023 | Xlif |
| Ortho Development Corporation | $147.21 | 2020 | |
| Osteocentric Technologies, INC. | $52.76 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Theragen, INC. | $19.53 | 2023 | Actastim-S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Behrens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.